Table 3 Gender and age at time of endoscopy as predictors of duodenal or gastric polyps
Sum diameter of duodenal polyps | Gastric polyp count | ||||
|---|---|---|---|---|---|
All participants (n = 150) | |||||
Gender: Male % (n) | 42% (n = 62) | Chi sq. = 0.63 | p-value = 0.4259 | Chi sq. = 0.28 | p-value = 0.5991 |
Age at Endoscopy | Median (Q1-Q3) | Spearman = 0.14 | p-value = 0.0873 | Spearman = 0.19 | p-value = 0.0191 |
Exclude current smokers (n = 128) | |||||
Gender: Male % (n) | 41% (n = 53) | Chi sq. = 0.3685 | p-value = 0.5438 | Chi sq. = 0.3022 | p-value = 0.5825 |
Age at Endoscopy | Median (Q1-Q3) Spearman = 0.12 | p-value = 0.1643 | Spearman = 0.21 | p-value = 0.0197 | |
Exclude NSAID use in past 3 months (n = 133) | |||||
Gender: Male % (n) | 41% (n = 55) | Chi sq. = 1.0689 | p-value = 0.3012 | Chi sq. = 0.3216 | p-value = 0.5706 |
Age at Endoscopy | Median (Q1-Q3) Spearman = 0.12 | p-value = 0.1643 | Spearman = 0.21 | p-value = 0.0197 | |
Exclude non-genetic testers (n = 140) | |||||
Gender: Male % (n) | 41% (n = 55) | Chi sq. = 1.0689 | p-value = 0.3012 | Chi sq. = 0.3216 | p-value = 0.5706 |
Age at Endoscopy | Median (Q1-Q3) Spearman = 0.12 | p-value = 0.1643 | Spearman = 0.21 | p-value = 0.0197 | |